Proton Pump Inhibitor (PPI) Inappropriate Use and Economic Burden in Chinese Population (ECHO)

AstraZeneca

Status: Completed

Conditions: Gastrointestinal Disease

Study type: Observational

Funder types: Industry

Identifiers

NCT03118778

D9612R00010

Details and patient eligibility

About

This is a descriptive retrospective database analysis study in using database. All patients with a physician PPI prescription will be selected to estimate the PPI inappropriate use.

Full description

Study primary objective is to identify the inappropriate use of PPI (overall, outpatient & inpatient).

Enrollment: 90,895 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients in 2015 China Health Insurance Research Association (CHIRA) database.
• Patients had PPI prescription during Jan. 2015 to Dec. 2015 will be selected to estimate the PPI inappropriate use.

Exclusion criteria

• Patients without data of treatment information.